Bank of America’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-9,839
| Closed | -$4K | – | 6728 |
|
2016
Q3 | $4K | Sell |
9,839
-10,517
| -52% | -$4.28K | ﹤0.01% | 5922 |
|
2016
Q2 | $9K | Buy |
20,356
+5,861
| +40% | +$2.59K | ﹤0.01% | 5734 |
|
2016
Q1 | $20K | Sell |
14,495
-26,439
| -65% | -$36.5K | ﹤0.01% | 5323 |
|
2015
Q4 | $60K | Buy |
40,934
+16,148
| +65% | +$23.7K | ﹤0.01% | 5004 |
|
2015
Q3 | $39K | Buy |
24,786
+4,316
| +21% | +$6.79K | ﹤0.01% | 5049 |
|
2015
Q2 | $35K | Sell |
20,470
-75
| -0.4% | -$128 | ﹤0.01% | 5110 |
|
2015
Q1 | $29K | Buy |
20,545
+6,500
| +46% | +$9.18K | ﹤0.01% | 4911 |
|
2014
Q4 | $21K | Sell |
14,045
-18,348
| -57% | -$27.4K | ﹤0.01% | 5188 |
|
2014
Q3 | $67K | Sell |
32,393
-42,412
| -57% | -$87.7K | ﹤0.01% | 4720 |
|
2014
Q2 | $228K | Sell |
74,805
-56,177
| -43% | -$171K | ﹤0.01% | 4127 |
|
2014
Q1 | $328K | Buy |
130,982
+97,370
| +290% | +$244K | ﹤0.01% | 3809 |
|
2013
Q4 | $167K | Buy |
33,612
+31,932
| +1,901% | +$159K | ﹤0.01% | 4298 |
|
2013
Q3 | $4K | Sell |
1,680
-323,921
| -99% | -$771K | ﹤0.01% | 5612 |
|
2013
Q2 | $723K | Buy |
+325,601
| New | +$723K | ﹤0.01% | 3426 |
|